Apellis Pharmaceuticals (APLS) Stock Chart & Stock Price History $20.15 +0.11 (+0.55%) As of 11:21 AM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock Apellis Pharmaceuticals Stock Price Performance The Apellis Pharmaceuticals (APLS) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 46.90%, with a year-to-date return of -36.85%. In the past month, the stock has increased 13.46%, reflecting recent market activity. As of the latest close, Apellis Pharmaceuticals traded at $20.04 with a market cap of $2.52 billion and volume of 1.55 million shares. Receive APLS Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Apellis Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance+3.65%1 Month Performance+13.46%3 Month Performance+10.71%Year-To-Date Performance-36.85%1 Year Performance-46.90% APLS Stock Chart for Friday, July, 18, 2025 APLS Chart by TradingView Apellis Pharmaceuticals Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization07/17/2025$19.75$20.04+1.47%$20.61$19.761.55 million shs$2.52 billion07/16/2025$19.35$19.75+2.07%$19.92$19.411.08 million shs$2.48 billion07/15/2025$19.91$19.35-2.81%$20.34$19.131.31 million shs$2.43 billion07/14/2025$19.44$19.91+2.42%$20.59$19.251.95 million shs$2.50 billion07/11/2025$19.53$19.44-0.46%$19.55$18.981.56 million shs$2.44 billion07/10/2025$19.21$19.53+1.67%$19.63$18.931.91 million shs$2.45 billion07/09/2025$17.89$19.21+7.38%$19.23$18.073.25 million shs$2.41 billion07/08/2025$17.42$17.89+2.70%$18.05$17.402.44 million shs$2.25 billion07/07/2025$17.99$17.42-3.14%$18.24$17.351.58 million shs$2.19 billion07/04/2025$17.99$17.99$18.26$17.73891,120 shs$2.26 billion Get the Latest News and Ratings for APLS and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Apellis Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 07/03/2025$17.82$17.99+0.93%$18.26$17.73891,120 shs$2.26 billion07/02/2025$17.87$17.82-0.28%$18.60$17.661.81 million shs$2.24 billion07/01/2025$17.31$17.87+3.24%$18.45$17.522.90 million shs$2.25 billion06/30/2025$17.43$17.31-0.69%$17.60$17.152.24 million shs$2.18 billion06/27/2025$18.40$17.43-5.27%$18.46$17.393.83 million shs$2.19 billion06/26/2025$18.39$18.40+0.05%$18.46$18.06769,022 shs$2.31 billion06/25/2025$18.61$18.39-1.18%$18.61$18.061.07 million shs$2.31 billion06/24/2025$17.62$18.61+5.62%$18.74$17.562.02 million shs$2.34 billion06/23/2025$17.69$17.62-0.40%$17.89$17.162.41 million shs$2.21 billion06/20/2025$17.76$17.69-0.39%$18.08$17.462.09 million shs$2.22 billion06/19/2025$17.76$17.76$17.94$17.571.42 million shs$2.23 billion06/18/2025$17.76$17.76$17.94$17.571.42 million shs$2.23 billion06/17/2025$18.30$17.76-2.95%$18.29$17.701.11 million shs$2.23 billion Related Companies BBIO Stock Price Chart VRNA Stock Price Chart BPMC Stock Price Chart ROIV Stock Price Chart ELAN Stock Price Chart RGC Stock Price Chart LEGN Stock Price Chart RVMD Stock Price Chart GRFS Stock Price Chart TGTX Stock Price Chart Receive APLS Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Apellis Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:APLS) was last updated on 7/18/2025 by MarketBeat.com Staff From Our PartnersElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredThis Could Be the Most Profitable Season of Your LifeInstitutional money is pouring in. Bitcoin ETFs are live. Altcoin adoption is accelerating. This is the sam...Crypto Swap Profits | SponsoredNew crypto laws coming. Will you win or lose?Washington’s first-ever “Crypto Week” could trigger a major Bitcoin surge — but one trader says don’t just buy...Brownstone Research | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredCritical AI announcement set to ignite AI 2.0 I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredI was wrong about TrumpI made a mistake. A mistake I feel very foolish about. After speaking with Donald Trump and some of his ...Porter & Company | Sponsored“All the land that you see I will give to you and your offspring forever…”“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Apellis Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Apellis Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
